References
- Chou TC, Talalay P. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 22:27–55.
- Courtenay VD, Mills J. 1978. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. British Journal of Cancer 37:261–268.
- De Groot JF, Gilbert MR. 2007. New molecular targets in malignant gliomas. Current Opinions in Neurology 20:712–718.
- Elkind MM, Sutton H. 1960. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiation Research 13:556–593.
- Fan QW, Weiss WA. 2006. Isoform specific inhibitors of PI3 kinase in glioma. Cell Cycle 5:2301–2305.
- Kuipers GK, Slotman BJ, Wedekind LE, Stoter TR, van den Berg J, Sminia P, Lafleur MV. 2007. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. International Journal of Radiation Biology 83:677–685.
- Lam GK. 1989. Analysis of interaction for mixtures of agents using the linear isobole. Bulletin of Mathematical Biology 51:293–309.
- Luttjeboer M, Kaspers GJK. 2006. Medulloblastoma: need for targeted treatment. Expert Review of Anticancer Therapy 6:649–652.
- Neijenhuis S, Begg AC, Vens C. 2005. Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent. Radiotherapy and Oncology 76:123–128.
- Puck TT, Marcus PI. 1956. Action of x-rays on mammalian cells. Journal of Experimental Medicine 103:653–666.
- Reuber MD. 1961. A transplantable bile-secreting hepatocellular carcinoma in the rat. Journal of the National Cancer Institute 26:891–897.
- Steel GG. 2002. Cell survival as a determinant of tumour response. In: G. G. Steel, editor. Basic clinical radiobiology, London: Arnold. pp 52–63.
- Steel GG, Peckham MJ. 1979. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. International Journal of Radiation Oncology Biology and Physics 5:85–91.
- Tubiana M, Courdi A. 1989. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiotherapy and Oncology 15:1–18.
- van Rijn J, van den Berg J. 1997. Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clinical Cancer Research 3:1775–1779.
- Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. 2005. (−)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Molecular Cancer Therapeutics 4:197–205.